High prevalence of low bone mass and associated factors in Korean HIV-positive male patients undergoing antiretroviral therapy

Journal of the International AIDS Society

Volumn 17, Issue , 2014, Pages

  Choe, Pyoeng Gyun ^a   Choi, Hyung Jin ^a,b   Kim, Nak Hyun ^a   Park, Wan Beom ^a   Song, Kyoung Ho ^a   Bang, Ji Hwan ^a   Kim, Eu Suk ^a   Park, Sang Won ^a   Kim, Hong Bin ^a   Oh, Myoung Don ^a   Kim, Nam Joong ^a  

^a Seoul National University   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

Author keywords

AIDS; HIV; Osteopenia; Osteoporosis

Indexed keywords

COLLAGEN;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; BONE MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DENSITOMETRY; ETHNIC DIFFERENCE; FEMUR NECK; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MIDDLE AGED; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; TREATMENT DURATION; UNIVERSITY HOSPITAL; WORLD HEALTH ORGANIZATION;

AIDS; HIV; OSTEOPENIA; OSTEOPOROSIS;

ABSORPTIOMETRY, PHOTON; ADULT; AGE FACTORS; ANTI-HIV AGENTS; BONE DENSITY; BONE RESORPTION; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; REPUBLIC OF KOREA;

EID: 84896828849     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.17.1.18773     Document Type: Article

References (24)

1. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-60. (Pubitemid 28135961)
2. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12:F51-8. (Pubitemid 28190689)
3. Powderly WG. Osteoporosis and bone health in HIV. Curr HIV/AIDS Rep. 2012;9:218-22.
4. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006;20:2165-74. (Pubitemid 44684707)
5. Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Lewiecki EM, et al. Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom. 2008;11:75-91. (Pubitemid 351602189)
6. Shin CS, Choi HJ, Kim MJ, Kim JT, Yu SH, Koo BK, et al. Prevalence and risk factors of osteoporosis in Korea: a community-based cohort study with lumbar spine and hip bone mineral density. Bone. 2010;47:378-87.
7. Jones S, Restrepo D, Kasowitz A, Korenstein D, Wallenstein S, Schneider A, et al. Risk factors for decreased bone density and effects of HIV on bone in the elderly. Osteoporos Int. 2008;19:913-8.
8. Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Lo Y, Klein RS. Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS. 2007;21:617-23.
9. Duvivier C, Kolta S, Assoumou L, Ghosn J, Rozenberg S, Murphy RL, et al. Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients. AIDS. 2009;23:817-24.
10. Triant VA, Brown TT, Lee H, Grinspoon SK. Fracture prevalence among human immunodeficiency virus (HIV)-infected versus HIV-negative patients in a large U.S. healthcare system. J Clin Endocrinol Metab. 2008;93:3499-504.
11. Carr A, Miller J, Eisman JA, Cooper DA. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS. 2001;15:703-9. (Pubitemid 32423217)
12. Tsai MS, Hung CC, Liu WC, Chen KL, Chen MY, Hsieh SM, et al. Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors. J Microbiol Immunol Infect. 2012. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=23073318
13. McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, et al. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis. 2010;51:937-46.
14. Rodriguez M, Daniels B, Gunawardene S, Robbins GK. High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses. 2009;25:9-14.
15. Teichmann J, Lange U, Discher T, Lohmeyer J, Stracke H, Bretzel RG. Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART). Eur J Med Res. 2009;14:59-64.
16. Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS. 2003;17:1917-23. (Pubitemid 37070277)
17. Fakruddin JM, Laurence J. HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity. Arch Virol. 2005;150:67-78. (Pubitemid 40171950)
18. Gibellini D, De Crignis E, Ponti C, Cimatti L, Borderi M, Tschon M, et al. HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation. J Med Virol. 2008;80:1507-14.
19. Grund B, Peng G, Gibert CL, Hoy JF, Isaksson RL, Shlay JC, et al. Continuous antiretroviral therapy decreases bone mineral density. AIDS. 2009;23:1519-29.
20. Hoy J, Grund B, Roediger M, Ensrud KE, Brar I, Colebunders R, et al. Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: the SMART body composition substudy. J Bone Miner Res. 2013;28:1264-74.
21. Amiel C, Ostertag A, Slama L, Baudoin C, N'Guyen T, Lajeunie E, et al. BMD is reduced in HIV-infected men irrespective of treatment. J Bone Miner Res. 2004;19:402-9. (Pubitemid 38787395)
22. Stellbrink HJ, Orkin C, Arribas JR, Compston J, Gerstoft J, Van Wijngaerden E, et al. Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study. Clin Infect Dis. 2010;51:963-72.
23. Grijsen ML, Vrouenraets SM, Wit FW, Stolte IG, Prins M, Lips P, et al. Low bone mineral density, regardless of HIV status, in men who have sex with men. J Infect Dis. 2013;207:386-91.
24. Stall R, Paul JP, Greenwood G, Pollack LM, Bein E, Crosby GM, et al. Alcohol use, drug use and alcohol-related problems among men who have sex with men: the Urban Men's Health Study. Addiction. 2001;96:1589-601.